Furthermore, diabetes treatments, such as metformin, sodium‐glucose cotransporter 2 (SGLT2) inhibitors, and glucagon‐like peptide‐1 (GLP‐1) receptor agonists, may play a role in the prevention of T2DM. The gene discussed is SLC5A2; the disease is diabetes mellitus.